triazolam has been researched along with Urinary Tract Diseases in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Midazolam was found to produce the greatest degree of amnesia and sedation at the time of anaesthetic induction and triazolam was found to have the greatest degree of residual sedation at the time of discharge, four hours postoperatively." | 2.66 | Placebo controlled comparison of midazolam, triazolam and diazepam as oral premedicants for outpatient anaesthesia. ( Forrest, P; Galletly, DC; Yee, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forrest, P | 1 |
| Galletly, DC | 1 |
| Yee, P | 1 |
1 trial available for triazolam and Urinary Tract Diseases
| Article | Year |
|---|---|
Placebo controlled comparison of midazolam, triazolam and diazepam as oral premedicants for outpatient anaesthesia.
Topics: Administration, Oral; Adult; Anesthesia Recovery Period; Anesthesia, General; Diazepam; Double-Blind | 1987 |